18.12.2012 Views

2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SURVEILLANCE FOLLOWING BREAST CANCER DIAGNOSIS<br />

Fig. 5. Palpable mass near scar; US shows typical features <strong>of</strong> fat<br />

necrosis.<br />

Abbreviation: US, ultrasound.<br />

TRAM flaps in our practice but may vary according to the<br />

distributions <strong>of</strong> types <strong>of</strong> reconstruction in your group. Mammography<br />

<strong>of</strong>ten demonstrates early dystrophic microcalcifications,<br />

which can simulate an aggressive recurrent DCIS<br />

(Fig. 4 and Fig. 5).<br />

Bilateral Mastectomy with Reconstruction<br />

Little is known about the utility <strong>of</strong> MRI as a diagnostic or<br />

surveillance tool after bilateral mastectomy with reconstruction.<br />

The current role <strong>of</strong> MRI in treating patients who have<br />

had a mastectomy is primarily as a diagnostic tool when<br />

clinical findings need clarification. Most recurrences adjacent<br />

to an implant are clinically palpable, and there is little<br />

evidence to support the use <strong>of</strong> MRI in asymptomatic postmastectomy<br />

with reconstruction patients. Patients who<br />

have undergone reconstruction with TRAM or deep inferior<br />

epigastric perforator flaps can be evaluated with MRI;<br />

however, routine surveillance is not common practice, as the<br />

risk <strong>of</strong> nonpalpable recurrence is extremely low. 30 MRI has<br />

been found useful in differentiating benign from malignant<br />

findings in patients with palpable abnormalities or pain<br />

after TRAM reconstruction (Fig. 6). 30<br />

Possible Developing Methods for<br />

Recurrence Detection<br />

To detect additional tumors or metastatic disease at an<br />

early stage, advanced imaging techniques, including diagnostic<br />

mammographic images, focused breast US, breast<br />

Authors’ Disclosures <strong>of</strong> Potential Conflicts <strong>of</strong> Interest<br />

Author<br />

Chris I. Flowers*<br />

Blaise P. Mooney*<br />

Jennifer S. Drukteinis*<br />

*No relevant relationships to disclose.<br />

Employment or<br />

Leadership<br />

Positions<br />

Consultant or<br />

Advisory Role<br />

1. Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after<br />

breast conservation therapy for early stage breast carcinoma: detection,<br />

treatment, and outcome in 266 patients. Cancer. 1999;85:437-446.<br />

2. Hietanen P, Miettinen M, Makinen J. Survival after first recurrence in<br />

breast cancer. Eur J Cancer Clin Oncol. 1986;22:913-919.<br />

MRI, and positron emission tomography imaging is <strong>of</strong>ten<br />

required. Breast-specific gamma imaging, PEM, and molecular<br />

breast imaging may have a problem-solving role, especially<br />

in the dense breast or where there are complications<br />

from ruptured silicone implants. Radiologists who have<br />

completed advanced training in breast cancer detection<br />

should interpret these imaging techniques. Imaging should<br />

be coupled with clinical exams by specialty-trained clinicians<br />

familiar with signs and symptoms <strong>of</strong> recurrence and<br />

should occur at set time intervals. The downside <strong>of</strong> these<br />

newer techniques is the radiation dose from the radioisotopes<br />

currently used, although new techniques are focused<br />

on reducing the radiation dose.<br />

Advanced reconstruction and radiation techniques can be<br />

difficult to interpret unless communication between members<br />

<strong>of</strong> the health care team is timely and accurate, and<br />

the radiologist is familiar with expected appearances. To<br />

achieve the goal <strong>of</strong> recurrence detection in the early stages,<br />

before it is clinically evident, radiologists and clinicians<br />

must be familiar with the behavior <strong>of</strong> subtypes <strong>of</strong> breast<br />

cancer and different surgical/medical/oncoplastic approaches<br />

to their treatment.<br />

Stock<br />

Ownership Honoraria<br />

REFERENCES<br />

Fig. 6. Vague nodularity on physical exam. US <strong>of</strong> nodularity<br />

showed no correlation. MRI demonstrates obvious local recurrence<br />

and metastases.<br />

Abbreviations: US, ultrasound; MRI, magnetic resonance imaging.<br />

Research<br />

Funding<br />

Expert<br />

Testimony<br />

Other<br />

Remuneration<br />

3. Nomura Y, Tsutsui S, Murakami S, et al. Prognostic impact <strong>of</strong> second<br />

cancer on the survival <strong>of</strong> early breast cancer patients. Int J Oncol. 1999;14:<br />

1103-1109.<br />

4. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up <strong>of</strong> a<br />

randomized trial comparing total mastectomy, lumpectomy, and lumpectomy<br />

63

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!